College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology (IDD & CB), Collaborative Innovation Center of Yangtza River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China.
College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology (IDD & CB), Collaborative Innovation Center of Yangtza River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China.
Bioorg Med Chem Lett. 2019 Sep 1;29(17):2498-2502. doi: 10.1016/j.bmcl.2019.07.014. Epub 2019 Jul 9.
Hexylselen is a novel submicromolar dual KGA/GDH inhibitor, which demonstrates potent inhibition of cancer cells with minimal toxicity. To further investigation its mechanism of action, we designed and synthesized its biotinylated derivative 2 as a novel probe. From commercially available starting material, 2 was obtained in 6 steps with 13.4% overall yield. It is notable that this practical synthetic route give a template for the preparation of unsymmetrical di-benzo[d][1,2]selenazol-3(2H)-ones. Based on probe 2, we developed a novel biomolecular interaction assay for convenient and reliable test of KGA allosteric inhibitors and confirmed that hexylselen as an allosteric inhibitor of KGA sharing the same binding pocket with BPTES but not with Ebselen via competitive experiments.
己基硒是一种新型的亚毫摩尔级的 KGA/GDH 双重抑制剂,对癌细胞具有很强的抑制作用,而毒性最小。为了进一步研究其作用机制,我们设计并合成了其生物素化衍生物 2 作为一种新型探针。从市售的起始原料出发,经 6 步反应以 13.4%的总收率得到 2。值得注意的是,这条实用的合成路线为制备非对称二苯并[d][1,2]硒唑-3(2H)-酮类化合物提供了一个模板。基于探针 2,我们开发了一种新的生物分子相互作用分析方法,用于方便可靠地测试 KGA 的别构抑制剂,并通过竞争性实验证实己基硒是 KGA 的别构抑制剂,与 BPTES 共享相同的结合口袋,但与 Ebselen 不同。